Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
Servier and MiNA Partner to Create Entirely New Class of Drugs
France-based Servier and U.
Boston Scientific Announces Agreement To Acquire Preventice Solutions, Inc.
MARLBOROUGH, Mass.
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
KENILWORTH, NJ, USA I January 20, 2021 I Merck (NYSE.
FDA Grants Priority Review to Genentech’s Esbriet (pirfenidone) for Unclassifiable Interstitial Lung Disease
SOUTH SAN FRANCISCO, CA, USA, January 21, 2021.
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A drug developed by Eli Lilly and Company dramatically reduced the risk of developing symptomatic COVID-19 among nursing home residents, the company found.
Mark Cuban launches low-cost generic drug company
Billionaire Mark Cuban launched a drug company this week that is “dedicated to producing low-cost versions of high-cost generic drugs” and pledges “radical transparency” in pricing.
Doptelet® (avatrombopag) approved in the EU for treatment of ITP
STOCKHOLM, Sweden I January 20, 2021 ISwedish Orphan Biovitrum AB (publ) (Sobi™) (STO.
Yesse Technologies secures another grant from The Michael J. Fox Foundation to sniff out Parkinson's disease
NEW YORK, Jan.
Japan to use data from outside clinical trials in drug approvals
TOKYO -- Japan's health ministry will issue new guidelines next fiscal year aimed at helping new drugs get to market faster, by allowing pharmaceutical companies to use data from outside of clinic...
Research establishes antibiotic potential for cannabis molecule
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.
SMC kicks of the new year by accepting five new medicines for NHS use
Five newly licensed medicines have been accepted for use on NHS Scotland by the Scottish Medicines Consortium (SMC) following its first meeting of 2021.
Xalkori bags FDA green light for rare paediatric non-Hodgkin lymphoma
The US Food and Drug Administration (FDA) has approved Pfizer’s Xalkori (crizotinib) for the treatment of paediatric patients and young adults with relapsed or refractory, systemic a...
71
72
73
74
75
76
77
78
79
